Severe COVID-19 is a biphasic illness, with an initial viral replication phase, followed by a
cascade of inflammatory events. Progression to severe disease is predominantly a function …

Since the emergence of COVID-19 in 2020, an unprecedented range of therapeutic options
has been studied and deployed. Healthcare providers have multiple treatment approaches …

The COVID-19 outbreak has quickly reached pandemic dimensions because of fast human-
to-human transmission. The first reports of the disease date from December 2019 in Wuhan …

The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an
unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in …

Broadly speaking, pharmacological treatments for COVID-19 can be divided into those
acting on upstream pathways early on in the disease process via suppression of viral …

On December 8, 2020, a 91-year-old woman made history as the first person to receive the
COVID-19 vaccine in the United Kingdom. Worldwide vaccination coverage will take time …

Background The course of disease in mild and moderate COVID-19 has many implications
for mobile patients, such as the risk of spread of the infection, precautions taken, and …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …

Background: The recent COVID-19 pandemic sweeping the globe has caused great concern
worldwide. Due to the limited evidence available on the dynamics of the virus and effective …

In December 2019, cases of unknown origin pneumonia appeared in Wuhan, China; the
causal agent of this pneumonia was a new virus of the coronaviridae family called severe …